https://www.businesswire.com/news/home/20221208005427/en/The-Native-Antigen-Company-Expands-Infectious-Disease-Portfolio-to-Include-Sudan-Ebolavirus-Boniface-1976-Glycoprotein
0
0
The Native Antigen Company Expands Infectious Disease Portfolio to Include Sudan Ebolavirus Boniface 1976 Glycoprotein - Business Wire
+ 65 more
12/8/22 at 10:07am
Organization
Business Wire
Authors
Details
41 words
Summarize
Health Native Antigen Company Expands Infectious Disease Portfolio BUSINESS WIRE Sudan Ebolavirus Boniface 1976
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines an
Create an account or login to join the discussion